Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Martha Gonzalez Griego"'
Autor:
F. Bach, Rafael Dominguez, Maria Teresa Solomon, Javier Figueredo, Normando Iznaga, Nelson Quintanal, Julio Cesar Selva, Mauricio Catala, Jose Vaquer, Jorge Juan Marinello, Jose Alert, Carolina Toledo, Tania Crombet Ramos, Patrcia Lorenzo Luaces, Silvia Salva, Martha Gonzalez Griego
Publikováno v:
Journal of Clinical Oncology. 30:2515-2515
2515 Background: Despite remarkable advances in multimodal therapy, high grade glioma (HGG) patients still face a poor prognosis. EGFR is well validated as a primary contributor of HGG initiation and progression. Nimotuzumab is a humanized monoclonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f330b4fd058dac11d1220bd9ba680ca
https://doi.org/10.1200/jco.2012.30.15_suppl.2515
https://doi.org/10.1200/jco.2012.30.15_suppl.2515
Autor:
Jose Vaquer, Rafael Domíngez, Martha Gonzalez Griego, Mauricio Catala, Tania Crombet, Javier Ballesteros, Nelson Quintanal, Jorge Juan Marinello, Patricia Lorenzo Luaces, Maria Teresa Solomon, Silvia Salva, Ferdinand Bach, Javier Figueredo, Julio Cesar Selva, Jose Alert, Juan Antonio Martell, Niurys de-Castro, Carolina Toledo
Publikováno v:
Addi. Archivo Digital para la Docencia y la Investigación
instname
BMC Cancer
instname
BMC Cancer
Background The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a humanized monoclonal antibody tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baddac458451659a46a9a9152177be4c